Status:
RECRUITING
Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Individuals with metabolic syndrome (MetS), particularly those with type 2 diabetes (T2D), and/or metabolic dysfunction-associated steatohepatitis or MASH face an elevated risk of major cardiovascular...
Eligibility Criteria
Inclusion
- everyone requiring liver transplantation for the treatment of a chronic liver disease
Exclusion
- MELD score \>25, viral replication
Key Trial Info
Start Date :
November 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 24 2029
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT07201649
Start Date
November 24 2025
End Date
November 24 2029
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, Alpes-maritimes, France, 06200